8/21/2026
Johnson & Johnson invests in Delix Therapeutics
Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.
Topic archive
u.s. drug enforcement administration
2 stories
8/18/2026
Ibogaine's legal status in the US explained
Ibogaine remains illegal in the US despite its potential therapeutic benefits.